Optimizing HPV Vaccine Introduction in Shanghai, China
Optimizing HPV Vaccine Introduction in Shanghai, China
Within low, middle, and upper income countries, low vaccine coverage results from both
 obstacles to vaccine access and low confidence in vaccine programs. Thus, it is critical to
 determine how best to enhance trust in vaccines as increasing numbers of vaccines are
 recommended for use. Even though the context accompanying the initial roll-out of a vaccine
 can have a large impact on people's perceptions of the vaccine and the corresponding disease,
 it is not clear how to best introduce a vaccine to increase public confidence and enhance
 uptake. The US roll-out of the human papillomavirus (HPV) vaccine framed HPV as a sexually
 transmitted infection, which proved to be an impediment to efforts to increase vaccine uptake
 >10 years after its introduction. This study will use an educational experiment, where
 parents of children will be exposed to information about the HPV vaccination in different
 ways. Parents will be introduced to the HPV vaccine through different scenarios with varying
 emphases (i.e., age at vaccination, types of transmission, type of cancer prevention). The
 aim will be to determine how the framing of the HPV vaccination across several dimensions
 affects (A) short-term and (B) sustained willingness to receive it. Parents' willingness to
 receive the vaccine will be assessed at this time and in the future.
Inclusion Criteria:

 -  Parents of children 2-18 years old.

 Exclusion Criteria:

 -  None